Follows the Addition of Mike Mathias as Chief Commercial Officer in Late 2024 and Jim Erickson as Chief Financial Officer in Late 2023
Saluda Medical, a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients with chronic neurological conditions, announced the appointment of Barry Regan as President and Chief Executive Officer effective as of July 14, 2025. In his most recent roles, Mr. Regan served as Executive Vice President, Global Operations at Dexcom and Senior Vice President, Global Operations at Wright Medical.
Health Technology Insights: Andy Garcia and Kairos Team Up to Empower Youth Mental Health
“We are thrilled to welcome Barry to Saluda and are fortunate to augment our leadership team with his extensive experience at a critical juncture,” said Doug Godshall, Chairman of the Board of Directors of Saluda Medical. “Combined with the recent appointments of Mike Mathias as Chief Commercial Officer and Jim Erickson as Chief Financial Officer, we are confident Saluda has the right team of seasoned and driven leaders in place to fully realize our vision of bringing scientifically-based spinal cord stimulation, and neuromodulation more broadly, into the future with our unparalleled dose-controlled, closed-loop platform. On behalf of the Board, we also extend our gratitude to Jim Schuermann for his contributions to the Company and wish him success in his future endeavors.”
Health Technology Insights: Putting Patients First: New Campaign Champions Safer, Smarter Healthcare
Bob Palmisano, Board Member of Saluda Medical and former Chief Executive Officer of Wright Medical added, “I am excited to work with Barry again following our time together at Wright. Barry’s proven track record of driving transformational change to support growth and profitability at large, global healthcare organizations, including at Wright and most recently at Dexcom, will undoubtedly benefit Saluda as the Company continues to scale commercial operations for the Evoke System.”
“I am thrilled to join Saluda as Chief Executive Officer at this exciting time,” said Barry Regan. “I look forward to working with Mike Mathias, Jim Erickson, Doug, Bob, and the entire team to continue establishing Saluda as a new standard of care in neuromodulation and transforming the lives of patients with chronic neurological conditions.”
Health Technology Insights: Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
